Clarithromycin and telithromycin increases interleukin-10 expression in the rat endometriosis model

Cytokine

Volumn 55, Issue 3, 2011, Pages 339-342

  Umezawa, Masakazu ^a,b   Tanaka, Naomi ^b   Takeda, Ken ^b   Ihara, Tomomi ^a   Sugamata, Masao ^a  

^a Tochigi Institute of Clinical Pathology   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Clarithromycin; Endometriosis; Immunomodulatory therapy; Interleukin 10; Telithromycin

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TELITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CHEMOKINE CCL2; CLARITHROMYCIN; ENDOMETRIOSIS; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; KETOLIDES; PERITONEUM; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UTERUS;

RATTUS;

EID: 79960892434     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.014     Document Type: Article

References (22)

1. Scott R.B., Wharton L.R. The effect of estrone and progesterone on the growth of experimental endometriosis in rhesus monkeys. Am J Obstet Gynecol 1957, 74:852-865.
2. Dizerega G.S., Barber D.L., Hodgen G.D. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 1980, 33:648-653.
3. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
4. Sugamata M., Ihara T., Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol 2005, 53:120-125.
5. Uchiide I., Ihara T., Sugamata M. Pathological evaluation of the rat endometriosis model. Fertil Steril 2002, 78:782-786.
6. Umezawa M., Sakata C., Tanaka N., Kudo S., Tabata M., Takeda K., et al. Cytokine and chemokine expression in a rat endometriosis is similar to that in human endometriosis. Cytokine 2008, 43:105-109.
7. Umezawa M., Sakata C., Tabata M., Tanaka N., Kudo S., Takeda K., et al. Diesel exhaust exposure enhances the persistence of endometriosis model in rats. J Health Sci 2008, 54:503-507.
8. Umezawa M., Takeda K., Ihara T., Sugamata M. Novel insights into pathology of endometriosis from a disease model induced by autotransplantation of endometrium. Inflam Regen 2010, 30:115-119.
9. Ihara T., Uchiide I., Sugamata M. Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis. Fertil Steril 2004, 81 (Suppl. 1):819-823.
10. López-Boado Y.S., Rubin B.K. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 2008, 8:286-291.
11. Sugamata M., Ihara T., Uchiide I., Konno R., Fujiwara H., Suzuki M., et al. Effects of clarithromycin on a rat endometriosis model: light and electron microscopic evaluation. Jpn J Antibiot 2004, 57 (Suppl. A):18-20.
12. Reed C.E., Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004, 114:997-1008.
13. Culić O., Eraković V., Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001, 429:209-229.
14. Williams A.C., Galley H.F., Watt A.M., Webster N.R. Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother 2005, 56:502-506.
15. Morikawa K., Watabe H., Araake M., Morikawa S. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996, 40:1366-1370.
16. Ackermann G., Rodloff A.C. Drugs of the 21st century: telithromycin (HMR 3647) the first ketolide. J Antimicrob Chemother 2003, 51:497-511.
17. Zeitlinger M., Wagner C.C., Heinisch B. Ketolides - the modern relatives of macrolides: the pharmacokinetic perspective. Clin Pharmacokinet 2009, 48:23-38.
18. Braun D.P., Gebel H., House R., Rana N., Dmowski N.P. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996, 65:1125-1129.
19. Kyama C.M., Debrock S., Mwenda J.M., D'Hooghe T.M. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003, 1:123.
20. Mosmann T.R. Properties and functions of interleukin-10. Adv Immunol 1994, 56:1-26.
21. Odukoya O.A., Ajjan R., Lim K., Watson P.F., Weetman A.P., Cooke I.D. The pattern of cytokine mRNA expression in ovarian endometriomata. Mol Hum Reprod 1997, 3:393-397.
22. Ho H.N., Wu M.Y., Chao K.H., Chen C.D., Chen S.U., Yang Y.S. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 1997, 12:2528-2533.